A Study to Investigate the Difference In Blood Levels of Camlipixant Between Different Camlipixant Formulation Prototypes
Clinical trial NCT07684586 · SUSPENDED
Trial details
- NCT number
- NCT07684586
- Sponsor
- GlaxoSmithKline
- Status
- SUSPENDED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-02
- Primary completion
- 2027-08-27
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.